MARKET

JAGX

JAGX

Jaguar Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5050
+0.0300
+6.32%
After Hours: 0.4500 -0.055 -10.89% 17:40 04/03 EDT
OPEN
0.4880
PREV CLOSE
0.4750
HIGH
0.5200
LOW
0.4750
VOLUME
120.86K
TURNOVER
--
52 WEEK HIGH
23.10
52 WEEK LOW
0.3507
MARKET CAP
25.83M
P/E (TTM)
-0.0056
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average JAGX stock price target is 4.000 with a high estimate of 5.00 and a low estimate of 3.000.

EPS

JAGX News

More
  • Jaguar Health to Host Investor Call April 6th at 8:30 a.m. Eastern Regarding Q4 2019 Financials & Business Updates
  • ACCESSWIRE · 11h ago
  • Napo Pharmaceuticals Expands Mytesi (Crofelemer) Patient Support Program
  • ACCESSWIRE · 1d ago
  • Jaguar Health Reports Its Napo Pharma Subsidiary To Expand NapoCares Program For Mytesi
  • Benzinga · 1d ago
  • Jaguar Health Clears Key Regulatory Hurdle on Path to Approval of Canalevia (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs
  • ACCESSWIRE · 2d ago

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About JAGX

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
More

Webull offers kinds of Jaguar Health Inc stock information, including NASDAQ:JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions.